Skip to Main Content

Paper Details

Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea.
J Natl Cancer Inst
5
2021
AMH, Amenorrhea, Antimullerian Hormone, Antimullerian hormone, amenorrhea, cyclophosphamide, docetaxel, doxorubicin, paclitaxel, participants, trastuzumab
Author NameAffiliation
Kathryn J RuddyMayo Clinic
Daniel J SchaidMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Peter A FaschingComprehensive Cancer Center Erlangen-European Metropolitan Region of Nuremberg, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen
  • 1 - 5

Datasets

Release 1.2